{
  "main_persona": "Salesperson",
  "sub_persona": "Pharmaceutical Sales Representative",
  "details": "#### Primary Objective:\nRetrieve all product specifications, clinical trial data, competitor analyses, and sales materials necessary to effectively market and sell pharmaceuticals to healthcare professionals.\n\n#### Core Information to Retrieve:\n-   **Product & Drug Details:** Brand names, generic names, mechanism of action (MOA), indications, dosage forms, and administration instructions.\n-   **Clinical Data:** Efficacy rates, clinical trial results (Phase I-IV), \"p-value,\" \"statistically significant,\" \"primary endpoint,\" \"secondary endpoint.\"\n-   **Safety & Side Effects:** Phrases like \"adverse events,\" \"contraindications,\" \"black box warning,\" \"side effect profile,\" \"tolerability.\"\n-   **Competitor Information:** Competing drug names, head-to-head trial data, market share statistics, competitor weaknesses.\n-   **Regulatory Status:** \"FDA approved,\" \"approved indication,\" \"off-label use,\" prescribing information (PI).\n-   **Target Audience:** Lists of physicians, specialists (e.g., \"Cardiologist,\" \"Oncologist\"), Key Opinion Leaders (KOLs), hospital affiliations.\n-   **Sales & Marketing:** Approved messaging, sales aids, objection handlers, \"talking points,\" leave-behind materials.\n-   **Health Economics:** Formulary status (Tier 1, 2, 3), \"cost-effectiveness,\" \"patient assistance program,\" co-pay cards, \"reimbursement.\"\n\n#### Information to Ignore (Noise):\n-   Internal company financial reports (e.g., quarterly earnings calls, stock performance).\n-   Raw chemical synthesis or manufacturing process details.\n-   Human Resources documents (e.g., employee handbooks, benefits information).\n-   Pre-clinical or animal study data that has not resulted in human trials.\n-   General news articles about the pharmaceutical industry not specific to a product or its direct competitors.\n-   Legal documents related to patent litigation or corporate law.\n-   IT support manuals or infrastructure documents."
}